ELEVAI Skincare
ELEVAI Skincare is a physician-dispensed and direct-to-consumer skincare company that develops exosome-based regenerative skincare and haircare products powered by its proprietary Cell Zero Exosomes™ technology, selling through 300+ authorized U.S. clinic providers and its own e-commerce platform.
- Company typePrivate
- Founded2017
- HeadquartersNewport Beach, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What ELEVAI Skincare does
ELEVAI Skincare is a Newport Beach, California-based skincare and haircare company that develops and sells biotechnology-driven regenerative products built around its proprietary Cell Zero Exosomes™ technology platform. The platform uses exosomes derived from ethically sourced human umbilical cord mesenchymal stem cells (hUMSCs) and a proprietary liquid-stabilization process that maintains exosome bioactivity without refrigeration or lyophilization. Its core products include Elevai Enfinity™ (an 8-in-1 at-home daily regenerative serum for anti-aging), Elevai Empower™ (a concentrated post-treatment serum designed for clinical use after microneedling, RF microneedling, laser, and chemical peel procedures), and the Root Renewal System™ (a three-step hair and scalp protocol launched in December 2024 in partnership with Yuva Biosciences that combines Cell Zero Exosomes™ with the YuvaBio® Y100™ botanical molecule). Manufacturing is performed in-house in an ISO 7 certified cleanroom under cGMP standards with five validated process stages and independent third-party QC testing.
The company operates a dual go-to-market model. On the clinical side, ELEVAI distributes through a network of more than 300 authorized U.S. clinic providers (dermatologists, plastic surgeons, and aesthetic practitioners) who integrate its products into in-office treatment protocols. On the consumer side, the company sells directly through a Shopify-powered e-commerce storefront (elevaiskincare.com) with a U.S.-only shipping policy, supported by a subscription option for recurring purchases. Pricing is unit-based, with the Root Renewal System™ publicly listed at $299 and professional SKUs priced through authorized provider channels only. ELEVAI Skincare is a wholly owned subsidiary of Elevai Labs Inc. (NASDAQ:ELAB, formerly PMGC), and its co-founder and CEO is Jordan Plews. Corporate and legal correspondence is directed to Pittsburgh, Pennsylvania, while operations and website controls are managed from Newport Beach, California.
The addressable market is the physician-dispensed and consumer exosome skincare category, where the global exosome skincare market is projected to reach US$633.2 million by 2033 at a 9.3% CAGR. ELEVAI competes on differentiated exosome sourcing (umbilical cord-derived rather than adipose-, platelet-, or plant-derived), shelf-stable liquid formulations, and in-house cGMP manufacturing, with brand visibility supported by earned media in Vogue, Marie Claire, Allure, Byrdie, PopSugar, and Beauty Inc.
ELEVAI Skincare firmographics
Firmographics- Name
- ELEVAI Skincare
- Legal name
- Elevai Skincare, Inc.
- Website
- https://elevaiskincare.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ELEVAI Skincare is a physician-dispensed and direct-to-consumer skincare company that develops exosome-based regenerative skincare and haircare products powered by its proprietary Cell Zero Exosomes™ technology, selling through 300+ authorized U.S. clinic providers and its own e-commerce platform.
- Ownership category
- akta.pro rank
ELEVAI Skincare industry classification
Industry- Product category
- Medical Aesthetics Skincare
- NAICS
- Cosmetics, Beauty Supplies, and Perfume Retailers (45612), Biological Product (except Diagnostic) Manufacturing (325414), Health and Personal Care Retailers (456)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Professional Skincare & Facial Treatments (CRABALAF)
Keywords
Where ELEVAI Skincare is headquartered
LocationHeadquarters
- HQ city
- Newport Beach
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ELEVAI Skincare business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel
Revenue model
- Professional/Clinical Product Sales: ELEVAI Skincare sells its professional-grade products (Elevai Empower™, Elevai Enfinity™) exclusively through authorized clinic providers. Clinics purchase products for use in in-office aesthetic treatments including microneedling, RF microneedling, laser therapies, and chemical peels. The company requires specific qualifications for provider registration to ensure products are sold under dermatologists or plastic surgeons.
- Direct-to-Consumer Product Sales: ELEVAI sells consumer products (Elevai Enfinity™ serum, Root Renewal System, Hair Kit) directly to consumers through its e-commerce platform. Consumer products extend and maintain clinical treatment results at home using the same Cell Zero Exosomes™ technology.
- Subscription Model: The company offers subscription options for consumers to maintain consistent product use, with the messaging 'Subscribe to maintain consistency and unlock your best results' indicating a recurring revenue opportunity.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Root Renewal System™ - 3-step hair and scalp protocol |
| Unit Pricing | Pay-as-you-go | Elevai Enfinity™ Exosome Serum |
| Unit Pricing | Pay-as-you-go | Elevai Empower™ Post-Treatment Serum |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
ELEVAI Skincare product offering
Product offeringCore offering
ELEVAI Skincare develops and sells exosome-based physician-dispensed skincare and haircare products built on its proprietary Cell Zero Exosomes™ platform derived from ethically sourced human umbilical cord mesenchymal stem cells. The company operates a dual-channel model, selling professional-grade products (Elevai Empower™) through a network of 300+ authorized clinics for use in microneedling, RF microneedling, laser, and chemical peel procedures, while also selling consumer products (Elevai Enfinity™ serum and the Root Renewal System™) directly to consumers via its e-commerce store.
Product overview
ELEVAI Skincare offers a portfolio of exosome-based skincare and haircare products built around its proprietary Cell Zero Exosomes™ technology platform. The core product line includes Elevai Enfinity™ (a daily at-home regenerative serum for anti-aging skincare), Elevai Empower™ (a professional-grade post-treatment serum for in-clinic use after procedures like microneedling and laser), and the Root Renewal System™ (a 3-step hair and scalp protocol). The dual-phase system combines in-office treatments with at-home care, allowing consumers to extend clinical results between provider visits. The company also sells through a network of 300+ authorized clinics.
Differentiator
Problem solved
Functional benefit
Brands
- Cell Zero Exosomes™: Proprietary exosome technology platform derived from ethically sourced newborn umbilical stem cells, serving as the core technology powering Elevai's skincare products.
Quantifiable outcome
- Users notice skin feeling calmer and more hydrated within 24-48 hours of first use
- +4 more outcomes
Companies that use ELEVAI Skincare
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
ELEVAI Skincare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ELEVAI Skincare partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Yuva BiosciencescoreELEVAI partnered with Yuva Biosciences to develop patent-pending exosome and mitochondrial technology for the S-Series Root Renewal System. This partnership combined Elevai's Cell Zero Exosomes™ technology with YuvaBio® Y100™ botanical molecules to create a three-part hair and scalp care solution targeting hair follicles at the cellular level. The Root Renewal System marks Elevai's first new product launch since 2022, creating new revenue streams and addressing growing demand in the high-growth hair care market.
Scale indicators6 records
Recent moves4 records
Expansion highlights5 records
ELEVAI Skincare competitors and assessment
Company assessmentBroad incumbents
- SkinMedica: Physician-dispensed skincare brand (owned by AbbVie/Allergan) that sells growth-factor and regenerative product lines through dermatologists and plastic surgeons — the closest large-scale incumbent to ELEVAI's medical-aesthetics channel strategy.
- SkinCeuticals: L'Oréal-owned physician-recommended skincare brand with a wide antioxidant and post-procedure portfolio; competes with ELEVAI for clinic shelf space in dermatology and plastic-surgery practices.
Direct peers
- DefenAge: Biotech-positioned clinical skincare brand sold through physicians and med-spas using defensin-peptide regenerative science, mirroring ELEVAI's scientist-driven, clinic-channel anti-aging positioning.
- iS Clinical: Professional skincare brand sold through physicians, spas and DTC, known for scientifically formulated regenerative and anti-aging serums — overlapping ELEVAI's dual clinical/DTC channel strategy.
- Plated Skin Science: Regenerative skincare line built around platelet-derived growth-factor technology, sold via physicians and DTC; competes with ELEVAI on the 'biologically active, exosome-adjacent' skincare narrative.
- ZO Skin Health: Dr. Obagi's physician-dispensed skincare line sold through dermatologists and med-spas with a strong anti-aging and post-procedure focus, overlapping ELEVAI's clinical channel.
- Senté Laboratories: Glycomics-based skincare sold through dermatologists and plastic surgeons, positioning itself on biotech active ingredients and post-procedure care, overlapping with ELEVAI's Enfinity™/Empower™ use cases.
- BENEV: Medical-grade skincare and exosome-based regenerative products sold to physicians and med-spas; competes head-to-head with Cell Zero Exosomes™ in microneedling and post-laser protocols.
- Alastin Skincare: Galderma-owned physician-dispensed brand built around post-procedure and regenerative skincare (e.g., TriHex Technology) distributed through dermatology and plastic-surgery clinics, directly overlapping ELEVAI's professional channel and post-treatment use cases.
Emerging players
- Calecim Professional: Stem-cell-conditioned-media-based professional skincare line used post-procedure in clinics and med-spas, making it a direct adjacent competitor to ELEVAI's biological skincare offering.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights5 records
Customer concentration
ELEVAI Skincare social profiles
Digital presenceELEVAI Skincare financial estimates
Financial estimateRevenue estimate
Valuation estimate
ELEVAI Skincare leadership team
Management profileNumber of profiles
Profiles1 record
ELEVAI Skincare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ELEVAI Skincare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ELEVAI Skincare
What does ELEVAI Skincare do?
ELEVAI Skincare develops and sells exosome-based physician-dispensed skincare and haircare products built on its proprietary Cell Zero Exosomes™ platform derived from ethically sourced human umbilical cord mesenchymal stem cells. The company operates a dual-channel model, selling professional-grade products (Elevai Empower™) through a network of 300+ authorized clinics for use in microneedling, RF microneedling, laser, and chemical peel procedures, while also selling consumer products (Elevai Enfinity™ serum and the Root Renewal System™) directly to consumers via its e-commerce store.
Is ELEVAI Skincare a public or private company?
ELEVAI Skincare is a private company. It is classified as corporate owned and is currently operating.
When was ELEVAI Skincare founded?
ELEVAI Skincare was founded in 2017. It employs 11 to 50 people.
Where is ELEVAI Skincare based?
ELEVAI Skincare is headquartered in Newport Beach, United States, in the North America region.
How does ELEVAI Skincare make money?
Three revenue lines are on record. Professional/Clinical Product Sales are the primary driver. The others are direct-to-Consumer Product Sales and subscription Model.
Who are ELEVAI Skincare's main competitors?
Broad incumbents on record are SkinMedica and SkinCeuticals. Direct peers are DefenAge, iS Clinical, Plated Skin Science, ZO Skin Health, Senté Laboratories, BENEV and Alastin Skincare. Calecim Professional is listed as an emerging player.
Does ELEVAI Skincare have an API?
No public API is recorded for ELEVAI Skincare.
What industry is ELEVAI Skincare in?
ELEVAI Skincare's product category is Medical Aesthetics Skincare. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 45612 and its SIC code is 2844.